Proposed Data Collection Submitted for Public Comment and Recommendations, 11535-11536 [2018-05242]

Download as PDF Federal Register / Vol. 83, No. 51 / Thursday, March 15, 2018 / Notices Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2018–05243 Filed 3–14–18; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–18–18PR; Docket No. CDC–2018– 0021] Proposed Data Collection Submitted for Public Comment and Recommendations DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. AGENCY: Decision To Evaluate a Petition To Designate a Class of Employees From the De Soto Avenue Facility in Los Angeles County, California, To Be Included in the Special Exposure Cohort National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention, Department of Health and Human Services. AGENCY: ACTION: Notice. NIOSH gives notice of a decision to evaluate a petition to designate a class of employees from the De Soto Avenue Facility in Los Angeles County, California, to be included in the Special Exposure Cohort under the Energy Employees Occupational Illness Compensation Program Act of 2000. SUMMARY: FOR FURTHER INFORMATION CONTACT: Stuart L. Hinnefeld, Director, Division of Compensation Analysis and Support, National Institute for Occupational Safety and Health, 1090 Tusculum Avenue, MS C–46, Cincinnati, OH 45226–1938, Telephone 877–222–7570. Information requests can also be submitted by email to DCAS@CDC.GOV. SUPPLEMENTARY INFORMATION: sradovich on DSK3GMQ082PROD with NOTICES Authority: 42 CFR 83.9–83.12. Pursuant to 42 CFR 83.12, the initial proposed definition for the class being evaluated, subject to revision as warranted by the evaluation, is as follows: Facility: De Soto Avenue Facility. Location: Los Angeles County, California. Job Titles and/or Job Duties: All employees of the Department of Energy, its predecessor agencies, and their contractors and subcontractors who worked at the De Soto Avenue Facility. Period of Employment: January 1, 1965 through December 31, 1995. Frank Hearl, Chief of Staff, National Institute for Occupational Safety and Health. [FR Doc. 2018–05277 Filed 3–14–18; 8:45 am] BILLING CODE 4163–19–P VerDate Sep<11>2014 17:34 Mar 14, 2018 Jkt 244001 The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled The World Trade Center Health Program (WTCHP): Impact Assessment and Strategic Planning for Translational Research—Focus Group Protocol. This project includes a series of focus groups with different stakeholder groups to explore their perspectives on the decisions that each of them makes in the context of the WTCHP. DATES: CDC must receive written comments on or before May 14, 2018. ADDRESSES: You may submit comments, identified by Docket No. CDC–2018– 0021 by any of the following methods: • Federal eRulemaking Portal: Regulations.gov. Follow the instructions for submitting comments. • Mail: Leroy A. Richardson, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS– D74, Atlanta, Georgia 30329. Instructions: All submissions received must include the agency name and Docket Number. CDC will post, without change, all relevant comments to Regulations.gov. SUMMARY: Please note: Submit all comments through the Federal eRulemaking portal (regulations.gov) or by U.S. mail to the address listed above. To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact Leroy A. Richardson, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton FOR FURTHER INFORMATION CONTACT: PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 11535 Road, NE MS–D74, Atlanta, Georgia 30329; phone: 404–639–7570; Email: omb@cdc.gov. SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to the OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below. The OMB is particularly interested in comments that will help: 1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; 2. Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; 3. Enhance the quality, utility, and clarity of the information to be collected; and 4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submissions of responses. 5. Assess information collection costs. Proposed Project The World Trade Center Health Program: Impact Assessment and Strategic Planning for Translational Research (Focus Group Protocol)— New—National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC). Background and Brief Description The James Zadroga 9/11 Health and Compensation Act of 2010, Public Law 111–347 (hereafter referred to as ‘‘the Zadroga Act’’), established the World Trade Center Health Program (WTCHP). Under subtitle C, the Zadroga Act requires the establishment of a research program on health conditions resulting E:\FR\FM\15MRN1.SGM 15MRN1 11536 Federal Register / Vol. 83, No. 51 / Thursday, March 15, 2018 / Notices from the 9/11 terrorist attacks. Thus, the CDC seeks a one-year OMB approval to collect information using focus groups. The WTCHP employs the Research-toCare (RTC) model strategic framework employed to prioritize, conduct, and assess research that informs excellence in clinical care for the population of responders and survivors affected by the 9/11 attack in New York City. The RTC model assumes the collective involvement of WTCHP stakeholders, including members, researchers, clinicians, and program administrators. It accounts for a variety of inputs that can affect the progress and impact of WTCHP research. These inputs include people and organizations (e.g., program members, providers, clinical centers of excellence, extramural researchers, and program staff), resources (e.g., technology, data centers, the NYC 9/11 Health Registry) and regulatory rules, principally the Zadroga Act. The program supports activities such as research prioritization, conduct of research, delivery of medical care, and iterative assessments of the translation of research to improvements in health care services and chronic disease management. These activities aim to produce tangible outputs such as research findings on WTC-related conditions, healthcare protocols, peerreviewed publications, quality assessment reports, and member and provider education products. Finally, the model anticipates short-, intermediate-, and long-term measurement of outcomes and serves as a communication tool for program planning and evaluation. In 2016, NIOSH contracted with the Research and Development (RAND) Corporation to evaluate the WTCHP RTC model including the research investments to date and the effectiveness with which the Program translates its research to different stakeholder groups. This work will ultimately provide guidance for the WTCHP on strategic directions, as well as produce generalizable knowledge about the translation of research into improved outcomes for individuals and populations exposed to disasters such as the 9/11 attacks. In the formative stage of our assessment, we propose to hold a series of focus groups with different stakeholder groups to explore their perspectives on translational research in the context of the WTCHP. The focus groups will each consist of a welldefined stakeholder group, and will last approximately two hours. These focus groups are necessary to gather background information on the relationship between different stakeholders and the WTCHP that will inform the development of more detailed interview protocols to be used with stakeholders in the next phase of this evaluation. Specific topics to be addressed in the focus groups will include: • Conceptualizations of research and ‘‘translational research.’’ • Relevance of WTCHP research topics, potential gaps, and stakeholder priorities. • Uses and usefulness of WTCHP research. • Barriers to conduct and use of WTCHP research. • Understanding of and perspectives on the relevance and usefulness of the Research-to-Care model. The total estimated burden hours is 360. There are no costs to the respondent other than their time and local travel to the location of the focus group. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Number of responses per respondent Average burden per response (in hours) Total burden (in hours) Type of respondents Form name WTCH Researchers ............................ WTCH Research Users ...................... WTCH Funders (NIOSH) .................... Focus Group Protocol ........................ Focus Group Protocol ........................ Focus Group Protocol ........................ 40 70 10 1 1 1 3 3 3 120 210 30 Total ............................................. ............................................................. ........................ ........................ ........................ 360 Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2018–05242 Filed 3–14–18; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention sradovich on DSK3GMQ082PROD with NOTICES [Docket No. CDC–2016–0029] Final Revised Vaccine Information Materials for Varicella Vaccine Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: VerDate Sep<11>2014 17:34 Mar 14, 2018 Jkt 244001 Under the National Childhood Vaccine Injury Act (NCVIA), CDC must develop vaccine information materials that all health care providers are required to give to patients/parents prior to administration of specific vaccines. On March 15, 2016, CDC published a notice in the Federal Register (81 FR 13794) seeking public comments on proposed updated vaccine information materials for polio vaccine and varicella vaccine. Following review of comments submitted and consultation as required under the law, CDC has finalized the materials for varicella vaccine. Copies of the final vaccine information materials for varicella vaccine are available to download from https://www.cdc.gov/ vaccines/hcp/vis/ or https:// www.regulations.gov (see Docket Number CDC–2016–0029). SUMMARY: PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 Beginning no later than June 1, 2018, each health care provider who administers varicella vaccine to any child or adult in the United States shall provide copies of the relevant vaccine information materials referenced in this notice, dated February 12, 2018, in conformance with the February 23, 2018 CDC Instructions for the Use of Vaccine Information Statements prior to providing such vaccinations. DATES: FOR FURTHER INFORMATION CONTACT: Suzanne Johnson-DeLeon (msj1@ cdc.gov), National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Mailstop A–19, 1600 Clifton Road NE, Atlanta, Georgia 30329. The National Childhood Vaccine Injury Act of 1986 (Pub. L. 99–660), as amended by section 708 of Public Law 103–183, added section 2126 to the Public Health SUPPLEMENTARY INFORMATION: E:\FR\FM\15MRN1.SGM 15MRN1

Agencies

[Federal Register Volume 83, Number 51 (Thursday, March 15, 2018)]
[Notices]
[Pages 11535-11536]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-05242]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-18-18PR; Docket No. CDC-2018-0021]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies the opportunity to comment on a proposed and/or 
continuing information collection, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on a proposed 
information collection project titled The World Trade Center Health 
Program (WTCHP): Impact Assessment and Strategic Planning for 
Translational Research--Focus Group Protocol. This project includes a 
series of focus groups with different stakeholder groups to explore 
their perspectives on the decisions that each of them makes in the 
context of the WTCHP.

DATES: CDC must receive written comments on or before May 14, 2018.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2018-
0021 by any of the following methods:
     Federal eRulemaking Portal: Regulations.gov. Follow the 
instructions for submitting comments.
     Mail: Leroy A. Richardson, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS-D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to Regulations.gov.

    Please note: Submit all comments through the Federal eRulemaking 
portal (regulations.gov) or by U.S. mail to the address listed 
above.


FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Leroy A. Richardson, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road, NE MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected; and
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses.
    5. Assess information collection costs.

Proposed Project

    The World Trade Center Health Program: Impact Assessment and 
Strategic Planning for Translational Research (Focus Group Protocol)--
New--National Institute for Occupational Safety and Health (NIOSH), 
Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    The James Zadroga 9/11 Health and Compensation Act of 2010, Public 
Law 111-347 (hereafter referred to as ``the Zadroga Act''), established 
the World Trade Center Health Program (WTCHP). Under subtitle C, the 
Zadroga Act requires the establishment of a research program on health 
conditions resulting

[[Page 11536]]

from the 9/11 terrorist attacks. Thus, the CDC seeks a one-year OMB 
approval to collect information using focus groups.
    The WTCHP employs the Research-to-Care (RTC) model strategic 
framework employed to prioritize, conduct, and assess research that 
informs excellence in clinical care for the population of responders 
and survivors affected by the 9/11 attack in New York City. The RTC 
model assumes the collective involvement of WTCHP stakeholders, 
including members, researchers, clinicians, and program administrators. 
It accounts for a variety of inputs that can affect the progress and 
impact of WTCHP research. These inputs include people and organizations 
(e.g., program members, providers, clinical centers of excellence, 
extramural researchers, and program staff), resources (e.g., 
technology, data centers, the NYC 9/11 Health Registry) and regulatory 
rules, principally the Zadroga Act.
    The program supports activities such as research prioritization, 
conduct of research, delivery of medical care, and iterative 
assessments of the translation of research to improvements in health 
care services and chronic disease management. These activities aim to 
produce tangible outputs such as research findings on WTC-related 
conditions, healthcare protocols, peer-reviewed publications, quality 
assessment reports, and member and provider education products. 
Finally, the model anticipates short-, intermediate-, and long-term 
measurement of outcomes and serves as a communication tool for program 
planning and evaluation.
    In 2016, NIOSH contracted with the Research and Development (RAND) 
Corporation to evaluate the WTCHP RTC model including the research 
investments to date and the effectiveness with which the Program 
translates its research to different stakeholder groups. This work will 
ultimately provide guidance for the WTCHP on strategic directions, as 
well as produce generalizable knowledge about the translation of 
research into improved outcomes for individuals and populations exposed 
to disasters such as the 9/11 attacks. In the formative stage of our 
assessment, we propose to hold a series of focus groups with different 
stakeholder groups to explore their perspectives on translational 
research in the context of the WTCHP. The focus groups will each 
consist of a well-defined stakeholder group, and will last 
approximately two hours.
    These focus groups are necessary to gather background information 
on the relationship between different stakeholders and the WTCHP that 
will inform the development of more detailed interview protocols to be 
used with stakeholders in the next phase of this evaluation. Specific 
topics to be addressed in the focus groups will include:
     Conceptualizations of research and ``translational 
research.''
     Relevance of WTCHP research topics, potential gaps, and 
stakeholder priorities.
     Uses and usefulness of WTCHP research.
     Barriers to conduct and use of WTCHP research.
     Understanding of and perspectives on the relevance and 
usefulness of the Research-to-Care model.
    The total estimated burden hours is 360. There are no costs to the 
respondent other than their time and local travel to the location of 
the focus group.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                         Average
                                                        Number of       Number of      burden per       Total
      Type of respondents             Form name        respondents    responses per   response (in   burden  (in
                                                                       respondent        hours)         hours)
----------------------------------------------------------------------------------------------------------------
WTCH Researchers...............  Focus Group                     40               1               3          120
                                  Protocol.
WTCH Research Users............  Focus Group                     70               1               3          210
                                  Protocol.
WTCH Funders (NIOSH)...........  Focus Group                     10               1               3           30
                                  Protocol.
                                                    ------------------------------------------------------------
    Total......................  ..................  ..............  ..............  ..............          360
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2018-05242 Filed 3-14-18; 8:45 am]
 BILLING CODE 4163-18-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.